Article Text

Download PDFPDF
Update on childhood rhabdomyosarcoma
  1. H P McDowell
  1. Correspondence to:
    H P McDowell, RLC NHS Trust Alder Hey, Liverpool, UK Dr H P McDowell, Consultant Paediatric Oncologist, RLC NHS Trust Alder Hey, Eaton Road, Liverpool L12 2AP, UK;
    Heather.McDowell{at}RLCH.NWEST.NHS.UK

Abstract

The overall survival of childhood rhabdomyosarcoma has improved dramatically over the past 10 years. Early diagnosis and appropriate referral to a specialised centre leading to an accurate and timely diagnosis reflects on overall outcome. Recent molecular studies have identified different biological subtypes resulting in the recognition of poorer subgroups and allowing more appropriate treatment to be administered. Clinical trials remain the cornerstone to further improve outcome, now carried out on an international basis.

  • rhabdomyosarcoma
  • survival
  • chemotherapy
  • EFS, event free survival
  • OS, overall survival
  • RMS, rhabdomyosarcoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes